📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
27
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
30%
🔄 Reverse Split
40%
• 50-day avg $1.37 approaching $1 threshold
• 10 months cash with weak price
📉 Score Deterioration
25%
• Score increased 13 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market Cap$16.24M
Shares Outstanding2.65M
Float2.07M
Cash$2.02M
Debt$196.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 52.0% shares (2025Q4 vs prior)
8 institutional holders · 97.5K shares
#1
UBS Group AG
68.4K shares
#2
CITADEL ADVISORS LLC
25.7K shares
#3
Tower Research Capital LLC (TRC)
2.8K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest7.8K
Days to Cover1.0
% of Float0.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for EPSM
📊 EPSM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EPSM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.